Lead
Everyday exposureHome & environmentAlso called · 8 names▾▴
lead paint, lead dust, lead in water, old paint, lead pipes, lead poisoning, Pb exposure, lead exposure
Heavy metal exposure
General information · effects depend on amount, timing, and how it is used. About these sources
Research strength: 3 / 5
MotherToBaby and WHO report that lead in a pregnant person's blood can cross the placenta, and CDC says lead stored in bones can return to blood during pregnancy. MotherToBaby reports studies linking high blood lead levels with miscarriage, but results are mixed: a 1999 study found an association, a 2010 study at lower levels did not, and a 2023 review rated the evidence very low certainty. MotherToBaby says CDC and ACOG recommend checking individual exposure risks and offering a blood test when a risk factor is present. CDC says a BLL of 5 μg/dL or higher should prompt an effort to identify the source, and WHO says no exposure level is known to be without harmful effects. Ask your provider about your situation.
Last reviewed: 2026-10-15
Sources
- MotherToBaby: LeadTeratology service
- CDC: Risk Factors and PregnancyUS government
- WHO: Lead poisoningInternational agency
- ACOG Committee Opinion 533: Lead Screening During Pregnancy and LactationProfessional society
- Borja-Aburto et al., Blood lead levels measured prospectively and risk of spontaneous abortionUS government
- Vigeh et al., Early pregnancy blood lead and spontaneous abortionUS government
- Santana et al., Gestational lead exposure and fetal/infant development systematic reviewUS government
Research strength: 3 / 5
WHO says lead exposure during pregnancy can reduce fetal growth and contribute to preterm birth; MotherToBaby reports high levels linked to poor growth, low birth weight, preterm delivery, preeclampsia, and stillbirth. A 2025 meta-analysis of 24 studies and 52,390 subjects found associations with preterm birth and small-for-gestational-age birth, but not low birth weight. A 2026 Georgia birth cohort found about 5 g lower mean birthweight per 1 μg/dL higher maternal blood lead, but no association with low birth weight or preterm birth. The studies report different findings, so these results do not predict an individual pregnancy outcome. CDC says BLLs of 5 μg/dL or higher should prompt source investigation and follow-up. Ask your provider about your situation.
Last reviewed: 2026-10-15
Sources
- MotherToBaby: LeadTeratology service
- CDC: Risk Factors and PregnancyUS government
- WHO: Lead poisoningInternational agency
- Ou et al., Meta-analysis of maternal exposure to heavy metals and adverse pregnancy outcomesUS government
- Manjavidze et al., Maternal blood lead and birthweight and preterm birth in Adjara, GeorgiaUS government
Research strength: 3 / 5
CDC says lead in blood can reach a fetus, and lead stored in bone may return to blood during pregnancy. MotherToBaby reports possible effects on brain development, learning, and behavior; a 2023 review rated human evidence for neurobehavioral outcomes very low certainty, while a separate 2023 cohort found an association with cognitive developmental delay around age 2. MotherToBaby says studies have not shown more birth defects, but a 2026 case-control study associated higher third-trimester lead with congenital heart defects. The study authors caution that late-pregnancy measurements cannot establish cause or show exposure during early heart development. CDC says people who think they were exposed can discuss a blood test with a provider. Ask your provider about your situation.
Last reviewed: 2026-10-15
Sources
- MotherToBaby: LeadTeratology service
- CDC: Risk Factors and PregnancyUS government
- WHO: Lead poisoningInternational agency
- Jia et al., Prenatal Lead Exposure, Genetic Factors, and Cognitive Developmental DelayUS government
- Santana et al., Gestational lead exposure and fetal/infant development systematic reviewUS government
- Wei et al., Prenatal exposure to vanadium and lead and congenital heart defectsUS government
Lead — Breastfeeding
Research strength: 3 / 5
CDC says a pregnant or lactating person with BLL ≥5 μg/dL should have the source investigated; at maternal BLL ≥5 and <40, breastfeeding can continue with infant BLL monitoring, and it should continue for infants with BLL <5. If an infant's BLL is rising or failing to decline by 5 μg/dL, CDC says the provider should contact the local health department for environmental sampling; if no outside source is found and maternal BLL ≥20 with infant BLL ≥5, CDC says milk may be a source and temporary pumping and discarding should be considered. At maternal BLL ≥40, CDC says to pump and discard until the level is <40, and it does not recommend testing milk. ACOG's 2012 opinion, reaffirmed in 2026, advises stopping if infant BLL >5 until maternal BLL decreases, which differs from CDC's current conditional approach. A 2026 study of 114 pairs found maternal blood lead predicted infant blood lead at six months, but months of exclusive breastfeeding were not associated with infant levels. Ask your provider about your situation.
Last reviewed: 2026-10-15
Sources
- MotherToBaby: LeadTeratology service
- CDC: Lead and BreastfeedingUS government
- ACOG Committee Opinion 533: Lead Screening During Pregnancy and LactationProfessional society
- CDC: Guidelines for the Identification and Management of Lead Exposure in Pregnant and Lactating WomenUS government
- O'Connor et al., Systematic review of contaminants in human milkUS government
- Barsalini et al., Maternal and infant heavy metal levels at six monthsUS government
- Wu et al., Individualized breastfeeding support in a case of elevated blood lead levelsUS government
Pregnancy
Miscarriage: Borja-Aburto et al. (1999) studied 668 women enrolled in the first trimester, with 35 miscarriages and 60 matched controls; the adjusted odds ratio was 1.8 (95% CI 1.1-3.1) for each 5 μg/dL increase in blood lead. Vigeh et al. (2010) followed 351 women, including 15 miscarriages; at mean BLL 3.8 μg/dL, case and ongoing-pregnancy levels did not differ significantly. Santana et al. (2023) reviewed 21 studies and rated evidence for miscarriage and neurobehavioral effects very low certainty. Growth and delivery: Ou et al. (2025) pooled 24 studies and 52,390 subjects; lead was associated with preterm birth (OR 1.40, 95% CI 1.17-1.68) and small-for-gestational-age birth (OR 1.66, 95% CI 1.04-2.66), but not low birth weight. The full-text review notes possible publication bias and cautions that the preterm estimate may be overstated. Manjavidze et al. (2026) studied 13,911 singleton births; each 1 μg/dL higher maternal BLL was associated with a mean 5.02 g lower birthweight, with no association with low birth weight or preterm birth. Neurodevelopment: Jia et al. (2023) studied 2,361 mother-child pairs and found higher maternal lead associated with cognitive developmental delay around age 2, especially among children with higher genetic risk. Birth defects: Wei et al. (2026) studied 97 cases and 194 controls and reported an association between third-trimester maternal lead and congenital heart defects. The authors state the result is not causal evidence and late-pregnancy levels do not establish exposure during early heart development. Eng et al. (2026) found gene-expression changes in human embryonic stem cells exposed to lead; this is mechanistic laboratory evidence, not a human pregnancy outcome.
Breastfeeding
MotherToBaby says breast-milk lead is usually lower than maternal blood lead, but this ratio was not independently verified in accessible source text and is not used in the summaries. O'Connor et al. (2026) reviewed 18 lead studies and found moderate-certainty correlations between maternal lead exposure and human-milk lead concentrations; this does not show that milk is the main source of infant lead. Barsalini et al. (2026) followed 114 Norwegian mother-infant pairs: maternal blood lead predicted infant blood lead at six months, but infant levels were not associated with months of exclusive breastfeeding. Wu et al. (2024) reported one dyad in which infant BLL changed after breastfeeding began and paused; prenatal transfer was also presumed, and the authors noted that controlled comparisons among prenatally exposed infants were absent. CDC's current guidance uses maternal and infant blood tests and does not recommend measuring lead in milk.
Lead is a naturally occurring heavy metal found in old paint, plumbing, soil, water, ceramic glazes, batteries, ammunition, some imported foods, traditional medicines, cosmetics, and some jobs or hobbies. MotherToBaby says lead mainly enters by breathing dust or swallowing particles, with small amounts entering through skin. Lead can stay in bones and teeth for years, then return to blood during pregnancy or breastfeeding.
What was tested
Human studies measured lead in maternal blood, cord blood, infant blood, and human milk. Outcomes included miscarriage, birth defects, fetal growth, preterm delivery, infant neurodevelopment, and infant blood lead. Most outcome evidence is observational, including cohorts and case-control studies; the 2024 breastfeeding report is a single dyad. Authors of that report noted that controlled comparisons of breastfeeding versus not breastfeeding in prenatally exposed infants had not been reported. No human study can use these results to predict an individual pregnancy outcome.
Miscarriage evidence
- Source A says
- MotherToBaby and CDC list miscarriage as a possible outcome of higher lead exposure. Borja-Aburto et al. reported higher odds with increasing blood lead. (MotherToBaby: Lead, CDC: Risk Factors and Pregnancy, Borja-Aburto et al., Blood lead levels measured prospectively and risk of spontaneous abortion)
- Source B says
- Vigeh et al. found no significant difference at a mean BLL below 5 μg/dL, and a 2023 systematic review rated the evidence for miscarriage very low certainty. (Vigeh et al., Early pregnancy blood lead and spontaneous abortion, Santana et al., Gestational lead exposure and fetal/infant development systematic review)
- Why they differ
- The studies examined different exposure levels and populations and used observational designs. A positive result in one study does not establish a general risk estimate.
- What the evidence shows overall
- Describe miscarriage as a possible association at higher exposure, while stating that human evidence is mixed and very low certainty. The reviewed sources do not establish an absolute chance for an individual pregnancy.
Birth-defect evidence
- Source A says
- MotherToBaby says studies have not shown an increased chance of birth defects. (MotherToBaby: Lead)
- Source B says
- A 2026 case-control study associated higher third-trimester maternal lead with congenital heart defects; the authors state the result is not causal evidence. (Wei et al., Prenatal exposure to vanadium and lead and congenital heart defects)
- Why they differ
- The newer study is one observational study and measured maternal lead in the third trimester, not during early heart development. Its association does not establish cause or a general birth-defect risk.
- What the evidence shows overall
- Replace broad reassurance with the newer finding and its limits. The available evidence does not establish a causal or absolute birth-defect risk.
Breastfeeding thresholds with elevated infant BLL
- Source A says
- ACOG's 2012 Committee Opinion, reaffirmed in 2026, advises discontinuing breastfeeding if the infant's BLL is greater than 5 μg/dL until maternal BLL decreases. The public ACOG abstract does not display this recommendation text. (ACOG Committee Opinion 533: Lead Screening During Pregnancy and Lactation, CDC: Guidelines for the Identification and Management of Lead Exposure in Pregnant and Lactating Women)
- Source B says
- CDC's 2025 page says breastfeeding can continue when maternal BLL is at least 5 and below 40 μg/dL with infant monitoring; it recommends considering temporary pumping and discarding only when no outside source is found, maternal BLL is at least 20, and infant BLL is at least 5. At maternal BLL at least 40, pump and discard until below 40. (CDC: Lead and Breastfeeding)
- Why they differ
- The older ACOG opinion uses a more restrictive infant BLL threshold. The current CDC page states the conditions for interruption more specifically and was updated in 2025. The full ACOG journal text is not publicly accessible from the linked page.
- What the evidence shows overall
- Keep the CDC's current maternal and infant thresholds exact, and disclose the older ACOG recommendation as a distinct approach rather than implying the recommendations are identical.
Routine prenatal screening
- Source A says
- MotherToBaby says CDC and ACOG recommend assessing each patient's exposure risk and offering a blood test when a risk factor is present. (MotherToBaby: Lead, ACOG Committee Opinion 533: Lead Screening During Pregnancy and Lactation, CDC: Risk Factors and Pregnancy)
- Source B says
- A 2026 perinatal-prevention review advocates universal lead screening during pregnancy. (Wessel, Prevention of Lead Exposure in the Perinatal Period)
- Why they differ
- The universal-screening proposal is an author's recommendation in a review, not a current agency guideline. Public agency and ACOG-linked advice describes risk assessment rather than routine testing of everyone.
- What the evidence shows overall
- Attribute the risk-based approach to current public guidance and retain the universal-screening proposal as a published but non-guideline view.
- MotherToBaby describes certified professional removal of lead paint, wet wiping and mopping in older homes, checking water, and keeping work clothes separate as ways to reduce exposure. (MotherToBaby: Lead)
- CDC says a pregnant person who thinks they may have been exposed can discuss a blood lead test with a health care provider; at BLL ≥5 μg/dL, the provider should attempt to identify the source and may involve local health and occupational medicine specialists. (CDC: Risk Factors and Pregnancy; Lead and Breastfeeding)
- WHO's clinical guidance says that at BLL ≥5 μg/dL, the source of lead exposure should be identified and appropriate action taken to end exposure. (WHO: Lead poisoning)
- CDC's breastfeeding guidance gives separate maternal and infant BLL monitoring thresholds, advises pumping and discarding at maternal BLL ≥40 μg/dL until BLL is below 40, and does not recommend testing breast milk. (CDC: Lead and Breastfeeding)
General research, not specific to pregnancy.
WHO describes lead exposure as affecting several body systems in children and adults. In children, it can affect brain development, attention, behavior, and learning; in adults, it can contribute to high blood pressure, cardiovascular problems, and kidney damage.
- WHO reports that lead can permanently affect children's brain development, including intelligence, attention, behavior, and educational outcomes. (WHO: Lead poisoning)
- WHO reports that long-term lead exposure in adults can increase the risk of high blood pressure, cardiovascular problems, and kidney damage. (WHO: Lead poisoning)
- CDC notes that even low blood lead levels can affect a child's intelligence, attention, and school achievement. (CDC: Lead and Breastfeeding)
- MotherToBaby: LeadTeratology serviceSecondary
- CDC: Risk Factors and PregnancyUS governmentSecondaryPage dated 2026-08-25Independent check
- CDC: Lead and BreastfeedingUS governmentSecondaryPage dated 2025-01-27Independent check
- CDC: Guidelines for the Identification and Management of Lead Exposure in Pregnant and Lactating WomenUS governmentSecondaryPage dated 2010-11-01Independent check
- ACOG Committee Opinion 533: Lead Screening During Pregnancy and LactationProfessional societySecondaryIndependent check
- WHO: Lead poisoningInternational agencySecondaryPage dated 2026-06-10Independent check
- Borja-Aburto et al., Blood lead levels measured prospectively and risk of spontaneous abortionUS governmentPrimaryIndependent check
- Vigeh et al., Early pregnancy blood lead and spontaneous abortionUS governmentPrimaryIndependent check
- Santana et al., Gestational lead exposure and fetal/infant development systematic reviewUS governmentPrimaryIndependent check
- Ou et al., Meta-analysis of maternal exposure to heavy metals and adverse pregnancy outcomesUS governmentPrimaryIndependent check
- Manjavidze et al., Maternal blood lead and birthweight and preterm birth in Adjara, GeorgiaUS governmentPrimaryIndependent check
- Jia et al., Prenatal Lead Exposure, Genetic Factors, and Cognitive Developmental DelayUS governmentPrimaryIndependent check
- Wei et al., Prenatal exposure to vanadium and lead and congenital heart defectsUS governmentPrimaryIndependent check
- Wessel, Prevention of Lead Exposure in the Perinatal PeriodUS governmentPrimaryIndependent check
- O'Connor et al., Arsenic, cadmium, lead, mercury, and PFAS exposure and human milk concentrations systematic reviewUS governmentPrimaryIndependent check
- Barsalini et al., Maternal and infant heavy metal levels at six monthsUS governmentPrimaryIndependent check
- Wu et al., Individualized support for breastfeeding in a case of elevated blood lead levelsUS governmentPrimaryIndependent check
- Eng et al., Transcriptomic effects of lead on human embryonic stem-cell ectoderm differentiationUS governmentPrimary
Last reviewed 2026-10-15
Independent check 2026-10-15
Not yet clinician-reviewed
Ask your provider about your situation.